October 11, 2017
The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System research initiative, today published Alignment Among Public Formularies in Canada - Part 1: General Overview.
September 27, 2017
A Patented Medicine Prices Review Board (PMPRB) Hearing Panel issued its decision relating to the medicine Soliris, manufactured and marketed in Canada by Alexion Pharmaceuticals Inc.
May 24, 2017
$1 billion increase from 2014-15 fueled largely by new, higher-cost drugs
May 16, 2017
Statement from Patented Medicine Prices Review Board Vice-chairperson Dr. Mitchell Levine on the launch of Health Canada’s consultation on potential changes to the Patented Medicines Regulations.
April 12, 2017
Proceedings to resume April 18, 2017 in Ottawa.